Offers no-hassle, free virtual visit with healthcare provider for patients to receive neffy for $0 co-pay if eligible with ...

QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most ...

An ER doctor reveals that using decongestants for cold symptoms carries risks that land people in the hospital each year.

The latest NCIS episode features references to Tony DiNozzo, now on his own spinoff, and McGee’s author alter ego, Thom E. Gemcity. [Warning: The below contains MAJOR spoilers for NCIS Season 23 ...

Evoke Pharma surges after QOL Medical announces $11 cash acquisition, a 140% premium, expected to close by the end of 2025.

QOL agreed to buy Evoke for $11 a share in a deal expected to close by the end of the year. QOL said it will fund the transaction with cash on hand. Shares of Evoke have more than doubled to $10.70 ...

A blocked nose at night might seem like a small inconvenience, but it can have a big impact on sleep and health ...

Investing.com -- Evoke Pharma (NASDAQ:EVOK) stock surged 134% following the announcement that the company has entered into a definitive agreement to be acquired by QOL Medical, a privately held ...

Veterans in Colorado die by suicide at a rate higher than among vets nationwide. Next Chapter helps some find a path to a stable life instead.

Cold mornings, radiators humming, and a chorus of snorts from the sofa raise quiet doubts in countless British homes. As ...

QOL Medical will buy Evoke for $11 per share, representing a premium of about 140% from the stock’s closing price on Monday. ...